• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Alterity Therapeutics Limited - American Depositary Shares (NQ: ATHE )

    2.450 +0.050 (+2.08%)
    Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 37,474
    Open 2.400
    Bid (Size) 2.450 (1)
    Ask (Size) 2.580 (30)
    Prev. Close 2.400
    Today's Range 2.400 - 2.595
    52wk Range 1.001 - 3.190
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    -1.21%
    -1.21%
    1 Month
    +133.31%
    +133.31%
    3 Month
    +97.92%
    +97.92%
    6 Month
    +37.52%
    +37.52%
    1 Year
    -3.54%
    -3.54%

    More News

    Read More
    Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics to Present at MST Financial Webinar
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
    From ALTERITY THERAPEUTICS LIMITED
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.